KIAA0947 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.15630000416556E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
8.05460000000702E-05 |
Normal-vs-Stage2 |
4.388200E-04 |
Normal-vs-Stage3 |
9.04220032182934E-11 |
Normal-vs-Stage4 |
1.08069999615878E-08 |
Stage1-vs-Stage2 |
3.792800E-01 |
Stage1-vs-Stage3 |
4.967600E-04 |
Stage1-vs-Stage4 |
5.921400E-03 |
Stage2-vs-Stage3 |
1.260230E-01 |
Stage2-vs-Stage4 |
2.298600E-01 |
Stage3-vs-Stage4 |
8.198600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
6.42570000541909E-08 |
Normal-vs-AfricanAmerican |
1.90719999999533E-05 |
Normal-vs-Asian |
1.420600E-01 |
Caucasian-vs-AfricanAmerican |
8.032200E-01 |
Caucasian-vs-Asian |
5.688800E-01 |
AfricanAmerican-vs-Asian |
5.075200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
6.99970004180983E-09 |
Normal-vs-Female |
6.30690000003042E-07 |
Male-vs-Female |
5.129600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.02579999999397E-05 |
Normal-vs-Age(41-60Yrs) |
2.9473999996199E-07 |
Normal-vs-Age(61-80Yrs) |
9.21849999668822E-08 |
Normal-vs-Age(81-100Yrs) |
9.84929999999773E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.732800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.089600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.495600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.611200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.725200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.064400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.075800E-01 |
Normal-vs-Grade 2 |
1.231810E-04 |
Normal-vs-Grade 3 |
3.5355000038706E-09 |
Normal-vs-Grade 4 |
1.79160020152835E-10 |
Grade 1-vs-Grade 2 |
2.707400E-01 |
Grade 1-vs-Grade 3 |
3.582300E-02 |
Grade 1-vs-Grade 4 |
4.984400E-03 |
Grade 2-vs-Grade 3 |
6.579300E-03 |
Grade 2-vs-Grade 4 |
3.803700E-04 |
Grade 3-vs-Grade 4 |
1.033380E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
6.972100E-04 |
Normal-vs-ccB subtype |
8.15639999984796E-09 |
ccA subtype-vs-ccB subtype |
3.003300E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.4135000003801E-07 |
Normal-vs-N1 |
8.988800E-04 |
N0-vs-N1 |
5.293200E-01 |
|
|